摘要
Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patients who had their CCT measured before and during monotherapy treatment with either latanoprost 0.05%, travoprost 0.004% or bimatoprost 0.03%. 62 patients were qualified for analysis. One eye of each subject was ran-
出处
《国际眼科杂志》
CAS
2003年第1期64-64,共1页
International Eye Science